Abstract
Epithelial ovarian cancer is the gynecological tumor with the highest mortality rate. Numerous findings have recently emerged about the value and extent of surgical therapy of this disease. Already applied to national and international standards and guidelines, these new developments must become part of clinical practice if patients are to benefit.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carboplatin / administration & dosage
-
Chemotherapy, Adjuvant
-
Chemotherapy, Cancer, Regional Perfusion
-
Combined Modality Therapy
-
Female
-
Humans
-
Infusions, Intravenous
-
Neoplasm Staging
-
Ovarian Neoplasms / drug therapy
-
Ovarian Neoplasms / mortality
-
Ovarian Neoplasms / pathology
-
Ovarian Neoplasms / surgery*
-
Paclitaxel / administration & dosage
-
Peritoneal Neoplasms / drug therapy
-
Peritoneal Neoplasms / pathology
-
Peritoneal Neoplasms / secondary*
-
Peritoneal Neoplasms / surgery
-
Prognosis
-
Reoperation
-
Survival Rate